|
KALBITOR (ecallantide) Data in HAE Presented at the American College of …
PharmaLive.com (press release) (NASDAQ: DYAX) announced today that two oral and two poster presentations featuring KALBITOR® (ecallantide) data in hereditary angioedema (HAE) were presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting held … KALBITOR(R) (ecallantide) Data in HAE Presented at the American College of … |
View full post on asthma – Google News